Topics

The sartan saga: Recapping the recalls

12:38 EDT 14 Aug 2019 | in-PharmaTechnologis

After 2018 saw numerous sartan drugs recalled for possible carcinogenic impurities, in 2019, the industry kept an eye on the regulatory issues that followed and the breakthroughs that have mitigated some of the risks.

Original Article: The sartan saga: Recapping the recalls

NEXT ARTICLE

More From BioPortfolio on "The sartan saga: Recapping the recalls"

Quick Search